0 Comments
0 Shares
377 Views
0 Reviews
Search
Discover new people, create new connections and make new friends
-
Please log in to like, share and comment!
-
Peptide and Oligonucleotide CDMO Market Growth Driven by RNA Therapeutics DemandThe rapid expansion of peptide therapeutics manufacturing, the accelerating demand for the RNA therapeutics CDMO market, and the growing reliance on GMP peptide synthesis services are reshaping the global biopharmaceutical manufacturing ecosystem. These advancements are central to the development of next-generation biologics and nucleic acid-based therapies, enabling faster,...0 Comments 0 Shares 273 Views 0 Reviews
-
Peptide Therapeutics Contract API Manufacturing Market Forecast Report by Product, Application & Region"Peptide Therapeutics Contract API Manufacturing Market Summary According to the latest report published by Data Bridge Market Research, the Peptide Therapeutics Contract API Manufacturing Market The global peptide therapeutics contract API manufacturing market size was valued at USD 3.48 billion in 2024 and is expected to reach USD 6.16 billion by 2032, at a CAGR of 9.00% during...0 Comments 0 Shares 223 Views 0 Reviews
-
Peptide Therapeutics Market Industry Size, Share and Business Opportunities Report"Peptide Therapeutics Market Summary According to the latest report published by Data Bridge Market Research, the Peptide Therapeutics Market Data Bridge Market Research analyses that the Peptide therapeutics market which was USD 44,699.15 million in 2023, would rocket up to USD 68,553.89 million by 2030, and is expected to undergo a CAGR of 6.3% during the forecast period. An...0 Comments 0 Shares 261 Views 0 Reviews
-
Peptide Therapeutics Market Set to Reach USD 70.7 Billion by 2032, Driven by Rising Demand for Targeted Therapies and Advances in Drug Delivery TechnologiesAccording to a report by Intel Market Research, the global Peptide Therapeutics Market was valued at USD 37.44 billion in 2024 and is projected to grow from USD 41.23 billion in 2025 to USD 70.7 billion by 2032, exhibiting a CAGR of 9.7% during the forecast period. The market is witnessing substantial growth as healthcare providers and pharmaceutical companies increasingly adopt peptide-based...0 Comments 0 Shares 239 Views 0 Reviews
-
"Peptide and Oligonucleotide CDMO Market Forecast: What to Expect as it Expands by 12.5% CAGR"In addition to regulatory challenges, CDMOs are also addressing the sustainability concerns of the biopharmaceutical industry. Companies are seeking manufacturing solutions that reduce waste, improve energy efficiency, and use sustainable raw materials. As the industry continues to evolve, the ability of CDMOs to offer eco-friendly and sustainable manufacturing practices will be crucial in...0 Comments 0 Shares 7K Views 0 Reviews1
-
Biopharmaceutical Innovation Driving Glycosylated Peptide Market to US$ 2.56 BillionGlycosylated Peptide is a biologically modified peptide in which sugar moieties are attached to improve structural stability and functional performance. This modification enhances its pharmacokinetic properties and therapeutic effectiveness in various medical applications. Glycosylated peptides are widely explored in biotechnology for developing advanced and targeted drug therapies. The...0 Comments 0 Shares 2K Views 0 Reviews